Bank of New York Mellon Corp
BankPosition in CRDF — Cardiff Oncology, Inc.
CIK 1390777
NEW YORK, NY
Position in CRDF
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$491,551
-$432,923 QoQ
Shares Held
303,428
-7.8% QoQ
Ownership
0.444%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. CRDF ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in CRDF
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $491,551 | 303,428 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $924,474 | 328,995 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $715,818 | 347,485 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,051,963 | 333,957 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,015,309 | 323,347 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,252,588 | 288,615 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $456,839 | 171,101 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $255,973 | 115,304 | Shares | Defined | 2024-07-25 | |
| 2023-12-31 | $21,237 | 14,350 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $19,945 | 14,350 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $21,093 | 14,350 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $23,677 | 14,350 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $20,089 | 14,350 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $22,098 | 14,350 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,866 | 14,485 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $286,168 | 115,391 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $723,458 | 120,376 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $746,290 | 112,056 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $692,982 | 104,208 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $132,871 | 14,349 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $885,796 | 62,424 | Shares | Other | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||